4//SEC Filing
FINCK BARBARA K 4
Accession 0000899243-18-019736
CIK 0001512762other
Filed
Jul 10, 8:00 PM ET
Accepted
Jul 11, 4:05 PM ET
Size
14.1 KB
Accession
0000899243-18-019736
Insider Transaction Report
Form 4
FINCK BARBARA K
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock, $0.0001 par value
2018-07-09$1.42/sh+500$710→ 37,543 total - Exercise/Conversion
Stock Option (right to buy)
2018-07-09−500→ 87,721 totalExercise: $1.42Exp: 2023-11-23→ Common Stock (500 underlying) - Exercise/Conversion
Common Stock, $0.0001 par value
2018-07-10$1.42/sh+1,260$1,789→ 38,303 total - Exercise/Conversion
Stock Option (right to buy)
2018-07-10−1,260→ 86,461 totalExercise: $1.42Exp: 2023-11-21→ Common Stock (1,260 underlying) - Sale
Common Stock, $0.0001 par value
2018-07-09$15.03/sh−500$7,515→ 37,043 total - Sale
Common Stock, $0.0001 par value
2018-07-10$15.00/sh−1,260$18,900→ 37,043 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.
- [F2]The shares underlying this option are fully vested and exercisable as of the date hereof.
Documents
Issuer
Coherus BioSciences, Inc.
CIK 0001512762
Entity typeother
Related Parties
1- filerCIK 0001242116
Filing Metadata
- Form type
- 4
- Filed
- Jul 10, 8:00 PM ET
- Accepted
- Jul 11, 4:05 PM ET
- Size
- 14.1 KB